Adaptive Biotechnologies reported revenue of $71.55M and net income of -$39.94M for the quarter ended Jun 2026, up 21.5% year over year. This income statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||
| Revenue | 39.47M | 37.93M | 38.62M | 43.66M | 47.83M | 55.20M | 37.65M | 7.70M | 37.92M | 45.78M | 41.87M | 43.19M | 46.44M | 47.46M | 52.44M | 58.88M | 93.97M | 71.68M | 70.87M | 71.55M | |||||||||||||
| Cost of RevenueCost of Rev | 14.19M | 14.36M | 13.19M | 13.22M | 14.91M | 16.59M | 18.68M | 17.91M | 19.35M | 19.62M | 18.05M | 19.32M | 16.67M | 18.05M | 16.98M | 18.00M | 18.16M | 18.22M | 18.71M | 20.16M | |||||||||||||
| Gross Profit | 25.28M | 23.57M | 25.43M | 30.44M | 32.92M | 38.61M | 18.97M | -10.21M | 18.57M | 26.17M | 23.82M | 23.87M | 29.77M | 29.41M | 35.46M | 40.88M | 75.82M | 53.46M | 52.17M | 51.39M | |||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||
| Amortization - Intangibles | 0.43M | 0.43M | 0.42M | 0.42M | 0.43M | 0.43M | 0.42M | 0.42M | 0.43M | 0.43M | 0.42M | 0.42M | 0.43M | 0.43M | 0.42M | 0.42M | 0.43M | 0.43M | 0.42M | 0.42M | |||||||||||||
| Research & DevelopmentR&D | 36.07M | 34.70M | 37.84M | 37.04M | 35.66M | 31.22M | 32.60M | 32.24M | 28.53M | 28.75M | 30.25M | 25.35M | 24.16M | 23.19M | 24.20M | 24.13M | 23.67M | 22.57M | 26.35M | 26.41M | |||||||||||||
| Selling, General & AdministrativeSG&A | 20.15M | 23.35M | 24.14M | 21.20M | 20.75M | 22.43M | 20.83M | 22.30M | 20.07M | 20.73M | 19.60M | 17.89M | 17.26M | 18.06M | 17.40M | 17.79M | 17.96M | 19.56M | 20.98M | 21.17M | |||||||||||||
| Restructuring CostsRestructuring | 1.04M | 0.68M | 0.19M | 0.09M | 0.64M | ||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 39.57M | 41.48M | 39.70M | 37.92M | 36.85M | 40.73M | 41.41M | 42.20M | 40.27M | 67.38M | 39.75M | 46.58M | 37.45M | 39.96M | 40.45M | 41.99M | 42.05M | 42.33M | 42.11M | 39.74M | |||||||||||||
| Operating ExpensesOpex | 95.79M | 99.53M | 101.69M | 96.16M | 93.26M | 94.38M | 94.84M | 96.74M | 88.88M | 116.85M | 90.64M | 90.51M | 79.07M | 81.30M | 82.05M | 83.92M | 83.68M | 84.45M | 90.08M | 87.32M | |||||||||||||
| Operating IncomeOp. Inc | -56.33M | -61.60M | -63.07M | -52.50M | -45.43M | -39.19M | -57.19M | -47.82M | -50.96M | -71.07M | -48.76M | -47.32M | -32.63M | -33.84M | -29.60M | -25.04M | 10.29M | -12.77M | -19.21M | -15.77M | |||||||||||||
| EBIT | -56.33M | -61.60M | -63.07M | -52.50M | -45.43M | -39.19M | -57.19M | -47.82M | -50.96M | -71.07M | -48.76M | -47.32M | -32.63M | -33.84M | -29.60M | -25.04M | 10.29M | -12.77M | -19.21M | -15.77M | |||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.65M | 3.58M | 3.53M | 3.60M | 3.65M | 3.01M | 2.99M | 2.70M | 2.94M | 2.95M | 2.90M | 2.95M | 2.97M | 2.95M | 2.89M | 2.69M | |||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.33M | 0.24M | 0.27M | 0.42M | 0.77M | 2.60M | 3.02M | 3.61M | 4.28M | 4.61M | 4.22M | 3.77M | 3.47M | 3.07M | 2.68M | 2.39M | 2.23M | 2.15M | 2.08M | 2.26M | |||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||
| EBT | -56.00M | -61.36M | -62.80M | -52.08M | -45.32M | -40.17M | -57.70M | -47.81M | -50.33M | -69.47M | -47.53M | -46.25M | -32.10M | -33.72M | -29.83M | -25.59M | 9.54M | -13.58M | -20.02M | -16.21M | |||||||||||||
| Tax ProvisionsTaxes | |||||||||||||||||||||||||||||||||
| Profit After TaxPAT | -56.00M | -61.36M | -62.80M | -52.08M | -45.32M | -40.17M | -57.70M | -47.81M | -50.33M | -69.47M | -47.53M | -46.25M | -32.10M | -33.72M | -29.85M | -25.61M | 9.55M | -13.58M | -20.03M | -39.94M | |||||||||||||
| Income from Non-Controlling InterestsInc. Minority | -0.10M | 0.08M | -0.06M | -0.04M | -0.04M | -0.04M | -0.00M | -0.00M | -0.03M | -0.03M | -0.03M | -0.03M | -0.03M | -0.03M | 0.02M | 0.02M | -0.00M | 0.02M | -0.15M | ||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -56.00M | -61.36M | -62.80M | -52.08M | -45.32M | -40.17M | -57.70M | -47.81M | -50.33M | -69.47M | -47.53M | -46.25M | -32.10M | -33.72M | -29.83M | -25.59M | 9.54M | -13.58M | -20.02M | -16.21M | |||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -56.00M | -61.36M | -62.80M | -52.08M | -45.32M | -40.17M | -57.70M | -47.81M | -50.33M | -69.47M | -47.53M | -46.25M | -32.10M | -33.72M | -29.83M | -25.59M | 9.54M | -13.58M | -20.02M | -16.21M | |||||||||||||
| Income towards Parent CompanyParent Net Inc | -56.00M | -61.36M | -62.80M | -52.08M | -45.32M | -40.17M | -57.70M | -47.81M | -50.33M | -69.47M | -47.53M | -46.25M | -32.10M | -33.72M | -29.83M | -25.59M | 9.54M | -13.58M | -20.02M | -16.21M | |||||||||||||
| Preferred Dividend PaymentsPref Dividends | |||||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -56.00M | -61.36M | -62.80M | -52.08M | -45.32M | -40.17M | -57.70M | -47.81M | -50.33M | -69.47M | -47.53M | -46.25M | -32.10M | -33.72M | -29.83M | -25.59M | 9.54M | -13.58M | -20.02M | -16.21M | |||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.40 | -0.44 | -0.44 | -0.37 | -0.32 | -0.28 | -0.40 | -0.33 | -0.35 | -0.48 | -0.33 | -0.31 | -0.22 | -0.23 | -0.20 | -0.17 | 0.06 | -0.09 | -0.13 | -0.10 | |||||||||||||
| EPS (Diluted) | -0.40 | -0.44 | -0.44 | -0.37 | -0.32 | -0.28 | -0.40 | -0.33 | -0.35 | -0.48 | -0.33 | -0.31 | -0.22 | -0.23 | -0.20 | -0.17 | 0.06 | -0.09 | -0.13 | -0.10 | |||||||||||||
| Shares Outstanding | 140.83M | 140.35M | 141.70M | 142.36M | 142.93M | 142.52M | 143.51M | 144.40M | 144.70M | 144.38M | 145.79M | 147.41M | 147.52M | 147.10M | 149.20M | 152.08M | 152.43M | 151.72M | 155.52M | 159.86M | |||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 140.83M | 140.35M | 141.70M | 142.36M | 142.93M | 142.52M | 143.51M | 144.40M | 144.70M | 144.38M | 145.79M | 147.41M | 147.52M | 147.10M | 149.20M | 152.08M | 163.16M | 151.72M | 155.52M | 159.86M | |||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 141.03M | 141.39M | 142.18M | 142.78M | 142.99M | 143.11M | 144.28M | 144.65M | 144.77M | 145.08M | 147.37M | 147.46M | 147.56M | 147.77M | 151.92M | 152.23M | 152.58M | 153.78M | 159.70M | 159.06M | |||||||||||||
| EBITDA | -56.33M | -61.60M | -63.07M | -52.50M | -45.43M | -39.19M | -37.10M | -24.82M | -29.83M | -9.96M | -28.18M | -18.32M | -11.33M | -11.80M | -9.22M | -6.07M | 30.67M | 8.48M | 12.14M | -15.77M | |||||||||||||
| Interest ExpensesInt Expense | 0.65M | 3.58M | 3.53M | 3.60M | 3.65M | 3.01M | 2.99M | 2.70M | 2.94M | 2.95M | 2.90M | 2.95M | 2.97M | 2.95M | 2.89M | 2.69M | |||||||||||||||||
| Tax Rate |